Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles
NEUROLOGY 2005;64:1326-1327
© 2005 American Academy of Neurology

April 26 Highlights

Hepatitis C (HCV) adds to risk of cognitive deficits

Cherner et al. examined how HCV infection increases the prevalence of neurocognitive deficits among patients with HIV or methamphetamine dependence as risk factors. The proportion impaired increased with the number of risk factors, and HCV infection was independently associated with deficient learning, abstraction, and motor skills.

see page 1343

The editorial by van Gorp and Hinkin considering this important article notes the negative impact of HCV infection upon cognitive functioning and equally importantly, the additive deleterious effects of methamphetamine abuse, HIV infection, and HCV infection on cognition. Because this study was not initially undertaken specifically to study the effects of HCV, some subject groupings in the study had fewer participants than would be optimal—only 83 were HCV infected. Also, alcohol use was high in their sample. However, this study draws attention to a burgeoning public health crisis: approximately 2.7 million Americans are infected with HCV, many of whom will develop neurologic dysfunction. The majority of HCV-infected adults have additional risk factors for cognitive impairment such as drug or alcohol abuse or HIV infection.

see page 1328

Cerebrotendinous xanthomatosis: A treatable ataxia


Figure. Gliosis of cerebellar dentate nuclei (gray arrow) surrounded by liquified defects (white arrows).

A video of the Clemen et al. patient shows the findings. Treatment with simvastatin and chenodeoxycholic acid was associated with stabilization of the neurologic syndrome.

see page 1476

Flat positioning for acute ischemic stroke?


Figure. MCA waveforms at 30, 15, and 0-degree HOB positions in a patient with acute ischemic stroke. The NIHSS score decreased by 3 points from 30 to 0 degree head position.

Despite lack of evidence for increased ICP, patients with acute ischemic strokes are frequently positioned at 30 degrees. Wojner-Alexander et al. augmented residual flow velocities by 20% by lowering head position from 30 to 0 degrees without increasing resistance.

see page 1354

Intensive insulin therapy protects the nervous system

In a randomized controlled trial, Van den Berghe et al. showed that preventing even moderate hyperglycemia with insulin during intensive care protected the central and peripheral nervous system, resulting in shortened intensive care dependency, and reduced intracranial pressure, diabetes insipidus, seizures, and critical illness polyneuropathy.

see page 1348

The editorial by Michael N. Diringer notes that these data provide compelling support for aggressive glucose control in critically ill surgical patients. Whether patients in neurologic intensive care units would reap similar benefits is not clear.

see page 1330

Combined carotid endarterectomy and CABG

Hill et al. found in Canada that stroke and death rate for combined CEA-CABG is 13.0% compared to 4.9% for CABG alone (RR 2.67 [95% CI 2.19 to 3.26]. Despite this, use of the combined procedure is increasing.

see page 1435

The editorial by Pullicino and Halperin notes the high morbidity of doing CEA and CABG at the same time. The authors further note that angioplasty and stenting may provide a new and better way to do what surgeons had hoped to do with endarterectomy, but these new procedures need to be studied prospectively.

see page 1332

CIDP induced by TNF{alpha} blockers

TNF{alpha} blockers may induce or worsen MS. Richez et al. described two patients treated by TNF{alpha} blockers who developed demyelinating neuropathy resembling CIDP.

see page 1468

The pipes of Pan

This reminiscence by Ludwig Gutmann provides a whimsical perspective on three generations of Neurology Department Chairs. It may prompt you to look for Dr. Gutmann’s first book of short stories.

see page 1483


Related Articles

Triple trouble: Cognitive deficits from hepatitis C, HIV, and methamphetamine
Wilfred G. van Gorp and Charles H. Hinkin
Neurology 2005 64: 1328-1329. [Full Text] [PDF]

Improved outcome with aggressive treatment of hyperglycemia: Hype or hope?
Michael N. Diringer
Neurology 2005 64: 1330-1331. [Full Text] [PDF]

Combining carotid endarterectomy with coronary bypass surgery: Is it worth the risk?
Patrick Pullicino and Jonathan Halperin
Neurology 2005 64: 1332-1333. [Full Text] [PDF]

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine
M. Cherner, S. Letendre, R. K. Heaton, J. Durelle, J. Marquie-Beck, B. Gragg, I. Grant, and the HIV Neurobehavioral Research Center Group
Neurology 2005 64: 1343-1347. [Abstract] [Full Text] [PDF]

Insulin therapy protects the central and peripheral nervous system of intensive care patients
G. Van den Berghe, K. Schoonheydt, P. Becx, F. Bruyninckx, and P. J. Wouters
Neurology 2005 64: 1348-1353. [Abstract] [Full Text] [PDF]

Heads down: Flat positioning improves blood flow velocity in acute ischemic stroke
Anne W. Wojner-Alexander, Zsolt Garami, Oleg Y. Chernyshev, and Andrei V. Alexandrov
Neurology 2005 64: 1354-1357. [Abstract] [Full Text] [PDF]

Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada
M. D. Hill, F. M. Shrive, J. Kennedy, T. E. Feasby, and W. A. Ghali
Neurology 2005 64: 1435-1437. [Abstract] [Full Text] [PDF]

Neuropathy resembling CIDP in patients receiving tumor necrosis factor-{alpha} blockers
C. Richez, P. Blanco, A. Lagueny, T. Schaeverbeke, and J. Dehais
Neurology 2005 64: 1468-1470. [Abstract] [Full Text] [PDF]

Cerebrotendinous xanthomatosis: A treatable ataxia
C. S. Clemen, E. A. Spottke, D. Lütjohann, H. Urbach, K. von Bergmann, T. Klockgether, and R. Dodel
Neurology 2005 64: 1476. [Full Text] [PDF]

Personal History: The Pipes of Pan
Ludwig Gutmann
Neurology 2005 64: 1483-1484. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS